Loading ENCOMPAS price...
We do not have quarterly financials for ENCOMPAS yet. Some companies, mainly insurers, file in a format we cannot read at the moment. Everything else on this page is current.
| Date | Party | Side | Qty | Price | Value |
|---|---|---|---|---|---|
| 2026-10-21 | RADIANT GLOBAL FUND-CLASS B PARTICIPATING SHARES | SELL | 2,42,000 | 241 | Rs 5.83 Cr |
| 2026-10-21 | MINERVA VENTURES FUND | BUY | 2,42,000 | 241 | Rs 5.83 Cr |
| 2026-08-17 | RADIANT GLOBAL FUND-CLASS B PARTICIPATING SHARES | BUY | 1,74,000 | 232 | Rs 4.04 Cr |
| 2026-08-17 | RJ HUF | SELL | 1,00,800 | 232 | Rs 2.34 Cr |
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.